Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Skye Bioscience (SKYE) reported Return on Capital Employed [ROCE] of -1404.80% for Q2 2026, down 1313.83 percentage points from -90.98% a year earlier and down 965.89 percentage points from the prior quarter.

Analysis

Skye Bioscience (SKYE) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2025, Skye Bioscience posted Return on Capital Employed [ROCE] of -137.39%, down 57.97 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +269.13 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -79.43% in FY2024 and -333.78% in FY2021 (+72.74 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2016.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of -329.06 percentage points over the last six quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2021 (a gain of 537.75 percentage points); the low point was Q2 2026 (a drop of 1313.83 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -438.91% (Q1 2026), -218.55% (Q4 2025) and -140.55% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Skye Bioscience 5.38 Mn -52.34 Mn - -889.31%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -889.31%
Jun 30, 2026 -1,404.80%
Mar 31, 2026 -438.91%
Dec 31, 2025 -218.55%
Sep 30, 2025 -140.55%
Jun 30, 2025 -90.98%
Mar 31, 2025 -56.41%
Dec 31, 2024 -41.47%
Sep 30, 2024 -29.98%
Jun 30, 2024 -56.50%
Mar 31, 2024 -100.53%
Jun 30, 2022 -1,218.88%
Mar 31, 2022 -206.80%
Dec 31, 2021 -114.42%
Sep 30, 2021 -94.62%
Jun 30, 2021 -164.92%
Mar 31, 2021 -219.36%
Dec 31, 2020 -230.92%
Sep 30, 2020 -632.37%
Dec 31, 2019 -745.17%
API Access

Skye Bioscience Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SKYE&period=max&api_key=YOUR_API_KEY